Norman Ng: Looking Forward to Dedicated Cancer Drug Insurance to Match the Rapid Advance of Anti-Cancer Innovations
Norman Ng/LinkedIn

Norman Ng: Looking Forward to Dedicated Cancer Drug Insurance to Match the Rapid Advance of Anti-Cancer Innovations

Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared on LinkedIn:

“Looking Forward to Dedicated Cancer Drug Insurance to Match the Rapid Advance of Anti-Cancer Innovations

We look forward to the launch of a new insurance product that specifically covers cancer drug expenses.

Insurance providers should move with the times. As innovative anti-cancer therapies are advancing rapidly, we need medical financial solutions to support the high cost of future novel cancer medicines, ease the financial burden on patients, and enable timely access to cutting-edge treatments.”

You can also read: Expert Discussion at COGC 2026: Who Should Carry the Cost of Cancer Care?

Norman Ng: Looking Forward to Dedicated Cancer Drug Insurance to Match the Rapid Advance of Anti-Cancer Innovations